Reports from IMIM Hospital del Mar Research Institute Provide New Insights into Bladder Cancer (Novel Oral Mtorc1/2 Inhibitor Tak-228 Has Synergistic Antitumor Effects When Combined With Paclitaxel or Pi3k Alpha Inhibitor Tak-117 In Preclinical ...)

Source :: Obesity, Fitness & Wellness Week. November 9, 2019, 1434
Publication Year :: 2019
Abstract: 2019 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Bladder Cancer have been published. According [...]

Subjects :: Paclitaxel
Physical fitness
Bladder cancer -- Prognosis -- Care and treatment
Cancer research
Obesity
Antineoplastic agents
Editors
Health

Tools